MFDS — authorised 13 July 1972
- Marketing authorisation holder: ACTIENT PHARMS
- Status: likely_approved
🇰🇷 Androgel in South Korea
MFDS authorised Androgel on 13 July 1972
Marketing authorisation
Androgel in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Androgel approved in South Korea?
Yes. MFDS authorised it on 13 July 1972.
Who is the marketing authorisation holder for Androgel in South Korea?
ACTIENT PHARMS holds the South Korean marketing authorisation.